| Literature DB >> 34295815 |
Renhao Yang1, Hui Wu1, Binghong Chen1, Wenhua Sun1, Xiang Hu1, Tianwei Wang1, Yubin Guo1, Yongming Qiu1, Jiong Dai1.
Abstract
OBJECTIVES: Endoscopic nasopharyngectomy (ENPG) is a promising way in treating recurrent nasopharyngeal carcinoma (rNPC), but sometimes may require therapeutic internal carotid artery (ICA) occlusion beforehand. Balloon test occlusion (BTO) is performed to evaluate cerebral ischemic tolerance for ICA sacrifice. However, absence of neurological deficits during BTO does not preclude occur of delayed cerebral ischemia after permanent ICA occlusion. In this study, we evaluate the utility of near-infrared spectroscopy (NIRS) regional cerebral oxygen saturation (rSO2) monitoring during ICA BTO to quantify cerebral ischemic tolerance and to identify the valid cut-off values for safe carotid artery occlusion. This study also aims to find out angiographic findings of cerebral collateral circulation to predict ICA BTO results simultaneously.Entities:
Keywords: balloon test occlusion; cerebral collateral circulation; endoscopic nasopharyngectomy; near-infrared spectroscopy cerebral oximeter; recurrent nasopharyngeal carcinoma; regional cerebral oxygen saturation
Year: 2021 PMID: 34295815 PMCID: PMC8290142 DOI: 10.3389/fonc.2021.674889
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Anatomic Configurations and Collateral Flow Configurations included in this study. Subgroup I: Type 1: A1 to A2 flow dominance: symmetric, cfPCA ipsilateral to tested side; Type 2: AcomA absence, complete posterior Circle ipsilateral to tested side. Subgroup II: A1 to A2 flow dominance: symmetric. Type 3: Tested side MCA area blood supply: the anterior Circle alone; Type 4: Tested side MCA area blood supply: both the anterior Circle and the posterior Circle; Type 5: Tested side MCA area blood supply: the posterior Circle alone. Subgroup III: A1 to A2 flow dominance: complete. Type 6: A1 absence ipsilateral to the tested side; Type 7: A1 absence contralateral to the tested side; Type 8: A1 absence ipsilateral to the tested side, cfPCA ipsilateral to tested side. Subgroup IV: A1 to A2 flow dominance: dominant. Type 9: A1 dominance ipsilateral to the tested side, complete posterior Circle on tested side; Type 10: A1 dominance contralateral to the tested side, complete posterior Circle on tested side; Type 11: A1 dominance ipsilateral to the tested side, PcomA absence on tested side; Type 12: A1 dominance contralateral to the tested side, PcomA absence on tested side.
Figure 2ROC curve analysis for the BTO-positive group. The purple line with orange dots showing ROC curve analysis for the BTO-positive group detected by drop in rSO2 value.
The summary of tested side MCA area blood supply categorization in (Subgroup II + Type 6) and its BTO results for BTO alone group.
| BTO Alone | |||
|---|---|---|---|
| Tested Side MCA Area Blood Supply | BTO-negative (%) (n = 24) | BTO-positive (%) (n = 2) | Total (%) (n = 26) |
| AC alone | 6 (23) | 0 (0) | 6 (23) |
| PC alone | 4 (15) | 2 (8) | 6 (23) |
| AC + PC | 14 (54) | 0 (0) | 14 (54) |
| Total | 24 (92) | 2 (8) | 26 (100) |
AC, the anterior Circle; PC, the posterior Circle.
The summary of tested side MCA area blood supply categorization in (Subgroup II + Type 6) and its BTO results for Therapeutic ICA Occlusion group.
| Therapeutic ICA Occlusion | |||
|---|---|---|---|
| Tested Side MCA Area Blood Supply | BTO-negative (%)(n = 25) | BTO false-positive (%)(n = 2) | Total (%)(n = 27) |
| AC alone | 10 (37) | 0 (0) | 10 (37) |
| PC alone | 3 (11) | 2 (7) | 5 (19) |
| AC + PC | 12 (44) | 0 (0) | 12 (44) |
| Total | 25 (93) | 2 (7) | 27 (100) |
AC, the anterior Circle; PC, the posterior Circle.
The summary of the sigh of reverse blood flow to ICA tested side MCA area blood supply in (Type 5 + Type 6) and its BTO results.
| Tested Side MCA Area Blood Supply: PC | |||
|---|---|---|---|
| Reverse Blood Flow to ICA (+/−) | BTO-negative (%)(n = 7) | BTO-positive + BTO false-positive (%)(n = 2 + 2) | Total (%)(n = 11) |
| Presence (+) | 6 (55) | 0 (0) | 6 (55) |
| Absence (−) | 1 (9) | 4 (36) | 5 (45) |
| Total | 7 (64) | 4 (36) | 11 (100) |
PC, the posterior Circle.
The summary of the relationship between the absence of Posterior Circle and its BTO results in Subgroup IV.
| Posterior Circle (+\−) | BTO-positive (%)(n = 3) | BTO-negative (%)(n = 12) | Total (%)(n = 15) |
|---|---|---|---|
| Presence (+) | 0 (0) | 10 (67) | 10 (67) |
| Absence (−) | 3 (20) | 2 (13) | 5 (33) |
| Total | 3 (20) | 12 (80) | 15 (100) |
Figure 3Cerebral angiography and cerebral rSO2 monitoring of Case Nos. 76 and 80. (A–G) Multi-side view of cerebral angiography. (H) Real-time rSO2 monitoring. The blue line represented rSO2 on the left cerebral hemisphere, the green line represented rSO2 on the right cerebral hemisphere, the yellow arrow indicates a sudden drop in rSO2.
Figure 4Cerebral angiography and cerebral rSO2 monitoring of Case No. 50. (A–H) Multi-side view of cerebral angiography. (I) Real-time rSO2 monitoring. The blue line represented rSO2 on the left cerebral hemisphere, the green line represented rSO2 on the right cerebral hemisphere. (J) CT scan of Case No. 50 after BTO and ICA occlusion, the yellow arrow indicates delayed cerebral infraction after therapeutic ICA occlusion.
Figure 5Cerebral angiography and cerebral rSO2 monitoring of Case No. 58. (A–H) Multi-side view of cerebral angiography. (I) Real-time rSO2 monitoring. The blue line represented rSO2 on the left cerebral hemisphere, the green line represented rSO2 on the right cerebral hemisphere, the yellow arrow indicates a sudden drop in rSO2.